ASSESSMENT OF WORLD HEALTH ORGANIZATION HIV DRUG RESISTANCE EARLY
WARNING INDICATORS Page 1 HIV/AIDS Programme ASSESSMENT OF WORLD …

Monitoring HIV Drug Resistance: Early Warning Indicators to Assess Performance of Thailand’s
Antiretroviral Treatment Program - PMC Back to Top Skip to main content NIH NLM Logo …

Abstract The European HIV Drug Resistance Guidelines Panel, established to make
recommendations to clinicians and virologists, felt that sufficient new information has …

Objectives The World Health Organization (WHO)'s HIV drug resistance (HIVDR) early
warning indicators (EWI s) measure antiretroviral therapy (ART)‐site factors associated with …

Background Malawi started rapid scale-up of antiretroviral therapy (ART) in 2004 and by
December 2006 had initiated over 85,000 patients on treatment. Early warning indicator …

The article describes the first limited experience of early warning indicators (EWIs) of HIV
drug resistance recommended by WHO; information on their content and order of use is …

Requests for permission to reproduce or translate WHO publications–whether for sale or for
noncommercial distribution–should be addressed to WHO Press through the WHO web site …

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the
World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of …

Antiretroviral treatment (ART) for HIV is being scaled up rapidly in resource-limited countries.
Treatment options are simplified and standardized, generally with one potent first-line …

Robust programmatic monitoring of factors associated with the emergence of human
immunodeficiency virus (HIV) drug resistance is an essential component of antiretroviral …